These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. "It Is a Big Spider Web of Things": Sensory Experiences of Autistic Adults in Public Spaces. MacLennan K; Woolley C; Andsensory E; Heasman B; Starns J; George B; Manning C Autism Adulthood; 2023 Dec; 5(4):411-422. PubMed ID: 38116051 [TBL] [Abstract][Full Text] [Related]
27. Exploring Identity Importance for Autistic Adults and Associations with Disclosure Experiences: A Brief Report. Love AMA; Cai RY; Edwards C; Gibbs V Autism Adulthood; 2023 Dec; 5(4):450-456. PubMed ID: 38116054 [TBL] [Abstract][Full Text] [Related]
28. Treatments for intractable constipation in childhood. Gordon M; Grafton-Clarke C; Rajindrajith S; Benninga MA; Sinopoulou V; Akobeng AK Cochrane Database Syst Rev; 2024 Jun; 6(6):CD014580. PubMed ID: 38895907 [TBL] [Abstract][Full Text] [Related]
29. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
30. [Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy]. Guo CC; Lu Y; Tang KJ; Xing HY; Tian Z; Rao Q; Wang M; Xiong DS; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):436-444. PubMed ID: 38964917 [No Abstract] [Full Text] [Related]
31. Undernutrition as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538 [TBL] [Abstract][Full Text] [Related]
32. Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma. Guo J; Wu Q; Li H; Liang C; Dai J; Zhang S; Dai C; Zhang J; Wen Y; Yang W Front Immunol; 2024; 15():1435934. PubMed ID: 39606226 [TBL] [Abstract][Full Text] [Related]
33. Assessment and treatment of gesture in neurogenic communication disorders: An international survey of practice. Caute A; Roper A; Dipper L; Stark BC Int J Lang Commun Disord; 2025; 60(1):e13136. PubMed ID: 39584407 [TBL] [Abstract][Full Text] [Related]
34. The Development and Evaluation of a Cross-Context Employment Program for Autistic Adolescents. Di Rezze B; O'Connor I; Georgiades S; Brennan R; Honeyman S; DiFazio A; Hall GB; Chan L; Steele R; Fallowfield E; Bennett T Autism Adulthood; 2023 Dec; 5(4):457-467. PubMed ID: 38116048 [TBL] [Abstract][Full Text] [Related]
35. Sexually transmitted infections in Spain: Current status. Del Romero J; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; García-Botella A; García-Lledó A; Hernández-Sampelayo T; Gómez-Pavón J; González Del Castillo J; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Gómez Castellá J; Palomo M; García Berrio R; Couso González A; Sotomayor C; Bouza E Rev Esp Quimioter; 2023 Oct; 36(5):444-465. PubMed ID: 37335757 [TBL] [Abstract][Full Text] [Related]
36. How to create accessible research summaries for the developmental language disorder community. Gasparini L; Ziegenfusz S; Turner N; Leitão S; St Clair MC; Jackson E Int J Lang Commun Disord; 2025; 60(1):e13142. PubMed ID: 39625399 [TBL] [Abstract][Full Text] [Related]
37. The (mis)use of evidence in contested rights: commentary on the UN Special Rapporteur on violence against women and girls' report on "prostitution and violence". Fried ST; Miller AM; Mallik R; Radačić I; Restrepo-Saldarriaga E Sex Reprod Health Matters; 2024 Dec; 32(1):2425530. PubMed ID: 39513331 [TBL] [Abstract][Full Text] [Related]
38. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
39. Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition. Fox T; Hunt BJ; Ariens RA; Towers GJ; Lever R; Garner P; Kuehn R Cochrane Database Syst Rev; 2023 Jul; 7(7):CD015775. PubMed ID: 37491597 [TBL] [Abstract][Full Text] [Related]